Loading...
EASL Studio - 2 November
(Live at 18:00 CET)

Season 3, Episode 9 - JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?

In this JHEP Live the faculty will be discussing the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections.
Faculty: Prof. Joerg Petersen (Moderator), Prof. Maria Buti (Faculty), Prof. Man-Fung Yuen (Faculty)
Articles of interest:
• Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
• N-acetyl galactosamine-conjugated antisense oligonucleotide (GSK3389404) in chronic hepatitis B patients on stable nucleos(t)ide therapy: Phase 2a, randomised, double-blind, controlled study
Related episodes
• Treatment of HBV-HDV coinfection in the era of entry inhibition
• JHEP Live: Stop Nuc in HBeAg negative patients
• Midday Talks: HBV and HDV drug development – Where do we stand and where are we going?

 

ℹ The episode will be broadcasted live on this page.

Watch on-demand

Watch previous EASL Studio episodes

Watch all EASL Studio episodes
Share
Back To Top